Cell Biotech Reports Operating Profit of 7.2 Billion KRW Last Year, Up 97% Year-on-Year

Published 15 Feb.2022 13:58(KST)

[Asia Economy Reporter Minji Lee] Cell Biotech announced on the 15th that its operating profit last year reached 7.25782 billion KRW, a 97.9% increase compared to the same period the previous year. Sales increased by 2.8% to 47.8 billion KRW, and net profit rose 223% to 10.3 billion KRW.

Hot Picks Today

"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"

"Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
Despite Warnings of "Do Not Enter, You May Not Make It Out Alive"... Foreign Tourist Stranded After Unauthorized Climb on Jeju Sanbangsan
Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
"Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③

The company stated, "The growth of the Duolac brand led to an increase in consolidated sales," and added, "Gains related to financial products contributed to the expansion of pre-tax profit growth."

한글 기사 보기

This content was produced with the assistance of AI translation services.